North American Brachytherapy Market

North American Brachytherapy Market Size, Share & Trends Analysis Report by Indication (Breast Cancer, Gynecological Cancer, Prostate Cancer, Skin Cancer, Brain Cancer, and Others), and by Type (Low-Dose Rate (LDR) Brachytherapy and High-Dose Rate (HDR) Brachytherapy) Forecast Period, 2020-2026
    Update Available - Forecast 2024-2030   

Published: Sep 2021 | Report Code: OMR2024098 | Category : Medical Devices | Delivery Format: /

The North American brachytherapy market is anticipated to grow at a CAGR of 3.3% during the forecast period. North America holds a major share in the global brachytherapy market due to the established research environment for various biotechnologies, the presence of major healthcare providers, and growing healthcare investment in the US and Canada. The availability of alternative therapy treatments and side effects associated with brachytherapy is the major restraining factors for the market.

Brachytherapy plays an important role in curing cancer patients and cannot be substituted or delayed with the growing tumors. However, COVID-19 had reduced the capacity of operating rooms, and the safety of healthcare professionals remained a major concern. Due to these reasons, brachytherapies were delay during the peak of the COVID-19 pandemic. 

The North American brachytherapy market is segmented based on indication and type. Based on indication, the brachytherapy market is segmented into breast cancer, gynecological cancer, prostate cancer, skin cancer, brain cancer, and others. Prostate cancer held a major share in the region as according to the American Cancer Society, 1 in 9 men are likely to be diagnosed with prostate cancer during their lifetime. While 1 in 39 men dies with this disease. Based on type, the brachytherapy market is segmented into LDR and HDR.

Some of the major companies serving the North American brachytherapy market include AngioDynamics, Inc., General Electric Co., Hologic, Inc., Isoray, Inc., Sensus Healthcare, Inc., Sun Nuclear Corp., Siemens Healthineers AG, and others. The market players are considerably contributing to the market growth by adopting various strategies including mergers and acquisitions, collaborations, to stay competitive in the market. For instance, in May 2021, General Electric Co. had acquired Zionexa for its PET imaging agent used in the biopsy of metastatic breast cancer patients.

Research Methodology

The market study of the North American brachytherapy market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for brachytherapy market player, medical device manufacturer, healthcare service providers, institutional investors, and other end-user for overall market analysis, and competitive analysis. The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models delivering insights into the market for better business decisions.

Market Segmentation

  1. North American Brachytherapy Market Research and Analysis by Indication
  2. North American Brachytherapy Market Research and Analysis by Type

The Report Covers

  • Comprehensive research methodology of the North American brachytherapy market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the North American brachytherapy market.
  • Insights about market determinants that are stimulating the North American brachytherapy market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. BY Region

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Market Determinants

3.1. Motivators

3.2. Restraints

3.3. Opportunities

4. Market Segmentation

4.1. North American Brachytherapy  Market by Indication

4.1.1. Breast Cancer 

4.1.2. Gynecological Cancer 

4.1.3. Prostate Cancer 

4.1.4. Skin Cancer

4.1.5. Brain Cancer 

4.1.6. Others

4.2. North American Brachytherapy Market by Type

4.2.1. Low-Dose Rate (LDR) Brachytherapy

4.2.2. High-Dose Rate (HDR) Brachytherapy

5. Regional Analysis

5.1. United States

5.2. Canada

6. Company Profiles 

6.1. AngioDynamics, Inc.

6.2. Becton, Dickinson and Co.

6.3. Best Medical International, Inc. 

6.4. Boston Scientific Corp. 

6.5. C4 Imaging LLC 

6.6. CIVCO Medical Solutions

6.7. General Electric Co.

6.8. Hologic, Inc. 

6.9. iCAD, Inc.

6.10. Isoaid, LLC

6.11. Isoray, Inc.

6.12. Merit Medical Systems, Inc.

6.13. Sensus Healthcare, Inc.

6.14. Sun Nuclear Corp.

6.15. Varian Medical Systems, Inc.

1. NORTH AMERICAN BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)

2. NORTH AMERICAN BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY INDICATION, 2019-2026 ($ MILLION)

3. NORTH AMERICAN BRACHYTHERAPY MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)

1. NORTH AMERICAN BRACHYTHERAPY MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)

2. NORTH AMERICAN BRACHYTHERAPY MARKET SHARE BY INDICATION, 2019 VS 2026 (%)

3. NORTH AMERICAN BRACHYTHERAPY MARKET SHARE BY TYPE, 2019 VS 2026 (%)

4. NORTH AMERICAN BRACHYTHERAPY MARKET SIZE, 2019-2026 ($ MILLION)

5. UNITED STATES BRACHYTHERAPY MARKET SIZE, 2019-2026  ($ MILLION)

6. CANADA BRACHYTHERAPY MARKET SIZE, 2019-2026 ($ MILLION)